Effective July 25 2019, the Canadian Patient Safety Institute has archived the Venous Thromboembolism (VTE) intervention. Though you may continue to access the Getting Started Kit online, it will no longer be updated.
VTE is associated with substantial morbidity and mortality as well is a major resource burden on the healthcare system.4,5 Development of DVT or PE is associated with increased patient mortality; the 30-day case fatality rate for DVT is two to five per cent and for PE is 33 per cent.6-9 The VTE Getting Started Kit provides you with evidence-based resources to assist you in decreasing thromboembolisms in your organization as well as in improving clinical outcomes from VTE patients.
This section includes:
1. Introduction to VTE
- Table 1 - Risk Factors for VTE
2. Incidence of VTE in Various Patient Groups
- Table 2 – Risk of Deep Vein Thrombosis in Hospitalized Patients
3. Incidence of Hospital-Associated VTE (HA-VTE)
4. Evidence of Benefit for VTE Prophylaxis
5. Costs of VTE
6. Quality Initiatives in VTE Prophylaxis
- Table 3 – Accreditation Canada VTE Prevention Tests for Compliance42
Section 1: Rationale for VTE Prophylaxis
This document was updated in January 2017
The Model for Improvement is designed to accelerate the pace of improvement using the PDSA cycle; a "trial and learn" approach to improvement based on the scientific method. Please refer to the
Improvement Frameworks GSK (2015) for additional information.
For more information, email
firstname.lastname@example.org or call 1-866-421-6933